Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$139.2M
+35.9% from 2023
Prescriptions
6,453
$21,567.52 per claim
Patients
1,180
1,299 prescribers
Total spending, 2024
$139.4M
$117,896.64 per patient
Medicare prescription drug plans paid $139.2M for Tukysa in 2024, for 6,453 prescriptions and refills to 1,180 patients (up 35.9% from 2023). The average cost per claim was $21,567.52.
California had the highest Medicare cost for Tukysa in 2024: $21.7M for 979 claims, followed by New York ($10.8M).
Francis J Cuevas, medical oncology in Franklin, WI, had the highest Medicare cost for Tukysa in 2024: 25 claims costing $626K.
Tukysa is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Seagen/Pfizer.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Francis J Cuevas Franklin, WI | Medical Oncology | 25 | Under 11 | $626K |
| Wassim McHayleh Altamonte Springs, FL | Hematology-Oncology | 35 | Under 11 | $596K |
| Nicole O Williams |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 988 | 4,812 | 906 | $91.2M |
| 2023 | 1,018 | 4,891 | 936 | $102.4M |
| 2024 | 1,299 | 6,453 | 1,180 | $139.2M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 28 |
| Under 11 |
| $568K |
| Eric Wirtschafter Santa Monica, CA | Internal Medicine | 22 | Under 11 | $528K |
| Kamal Haider Lakeland, FL | Hematology-Oncology | 19 | Under 11 | $491K |
| Kelly E McCann San Diego, CA | Hematology-Oncology | 19 | Under 11 | $486K |
| Elena Shagisultanova Philadelphia, PA | Medical Oncology | 23 | Under 11 | $485K |
| Heidi Smith Mason City, IA | Nurse Practitioner | 18 | Under 11 | $464K |
| Khalid Mahmood Webster, TX | Medical Oncology | 16 | Under 11 | $422K |
| Nina S Liu San Diego, CA | Hematology-Oncology | 16 | Under 11 | $419K |
| Liliana Bustamante Cape Coral, FL | Hematology-Oncology | 16 | Under 11 | $403K |
| Stephan B Rosenfeld Fayetteville, AR | Medical Oncology | 19 | Under 11 | $401K |
| Sreenivas V Rao Florence, SC | Hematology-Oncology | 16 | Under 11 | $399K |
| Saranya Chumsri Jacksonville, FL | Hematology-Oncology | 17 | Under 11 | $399K |
| Elizabeth A Byron Palm Springs, FL | Hematology-Oncology | 18 | Under 11 | $393K |
| Luis Baez Vallecillo San Juan, PR | Hematology-Oncology | 15 | Under 11 | $392K |
| Rahul R Naik Los Angeles, CA | Hematology-Oncology | 16 | Under 11 | $389K |
| Ann B Evangelista Philadelphia, PA | Nurse Practitioner | 19 | Under 11 | $388K |
| Reza Mostofi Torrance, CA | Hematology-Oncology | 15 | Under 11 | $385K |
| Meekoo Dhar Staten Island, NY | Hematology-Oncology | 14 | Under 11 | $373K |
| Douglas C Collins Atlanta, GA | Hematology-Oncology | 14 | Under 11 | $366K |
| Ana F Borgas Bellflower, CA | Hematology-Oncology | 17 | Under 11 | $363K |
| Suguna Chirla Castro Valley, CA | Hematology-Oncology | 14 | Under 11 | $361K |
| Nagaprasad Nagajothi Massillon, OH | Hematology-Oncology | 19 | Under 11 | $348K |
| Vincente Valero Houston, TX | Medical Oncology | 14 | Under 11 | $348K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Seagen/Pfizer PFE | 6,463 | $139.4M |